Immuneering Corporation · NASDAQ:IMRX
Gengos Andrew bought 25,000 Immuneering Corporation shares (Form 4)
Traded Nov 13, 2026 · Filed Nov 16, 2026
On Nov 13, 2026, Gengos Andrew (Chief Financial Officer) bought 25,000 Immuneering Corporation shares at US$3.58 for US$89,500, leaving 250,000 shares. Filed Nov 16, 2026 (Form 4).
- Bought
- 25,000 shares
- Price
- US$3.58
- Value
- US$89,500
- Holding after
- 250,000 shares
- Trading plan
- No
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 13, 2026 | Class A Common Stock | Buy | 25,000 | US$3.58 | 250,000 | Direct |
Source
Download original · View original at SEC
Related
- Immuneering Corporation
- Gengos Andrew
- Immuneering Corporation shareholders
- Schedule 13G · BlackRock, Inc. · Jul 28, 2026
- Form 4 · Zeskind Benjamin J. · Jun 24, 2026
- Form 4 · Hall Brett Matthew · Jun 16, 2026
- Schedule 13G/A · Zeskind Benjamin J. · Jan 22, 2026
- Schedule 13G/A · Empery Asset Management, LP · Jan 15, 2026